Interventional × Esophageal Neoplasms × Celecoxib × Clear all Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Phase 1 Terminated
10 enrolled
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Phase 1 Terminated
44 enrolled
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
Phase 2 Completed
35 enrolled
Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
Phase 2 Completed
A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer
Phase 2 Terminated
6 enrolled
Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2 Completed
14 enrolled
Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
Phase 2 Completed
39 enrolled